Alternative Effects of the Ubiquitin-Proteasome Pathway on Glucocorticoid Receptor Down-Regulation and Transactivation Are Mediated by CHIP, an E3 Ligase
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The ubiquitin/proteasome-dependent protein degradation pathway (UPP) is responsible for the accelerated down-regulation of glucocorticoid receptor (GR) levels in cells subjected to chronic glucocorticoid exposure. Whereas hormone-dependent down-regulation of GR operates in most cells, the receptor is not down-regulated after long-term glucocorticoid treatment of either cultured embryonic hippocampal neurons or the HT22 hippocampal cell line. In this report, we show that stable overexpression of the carboxy terminus of heat shock protein 70-interacting protein (CHIP) E3 ligase can restore hormone-dependent down-regulation of GR in HT22 cells. Proteasome inhibitor studies establish that ubiquitylated GR can be efficiently engaged with the proteasome upon CHIP overexpression, unlike the case in parental HT22 cells. In addition to its impact on GR down-regulation, CHIP overexpression alters the coupling between the UPP and GR transactivation. Unlike other steroid receptors whose transactivation properties are typically reduced upon proteasome inhibition, GR transactivation in HT22 cells and other cell lines is enhanced upon proteasome inhibition. However, in HT22 cells overexpressing CHIP, proteasome inhibition leads to a reduction in GR transactivation activity. Thus, the divergent response of a single transactivator (i.e. GR) to the UPP can be dictated by CHIP, an E3 ligase that also functions as a proteasome-targeting factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutation of this conserved Lys residue enhances the glucocorticoid-induced transcriptional activity of GR and blocks ligand-dependent down-regulation of GR80.”
From Corticosteroids (2016) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
STEROID RECEPTOR REGULATED TRANSCRIPTION OF SPECIFIC GENES AND GENE NETWORKS
Yamamoto, K. R. (1985) · Annual Review of Genetics · doi:10.1146/annurev.ge.19.120185.001233 · Cited by 1,872
Recognition of the polyubiquitin proteolytic signal
Thrower, J. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,716
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657
Cited by
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Glucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
“residue or the E3 ligase have been shown to modulate GR activity [37] [38].”
BackgroundRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
Comprehensive Overview of the Structure and Regulation of the Glucocorticoid Receptor
Vandevyver, S., Dejager, L., & Libert, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1010 · Cited by 265
The significance of glucocorticoid pulsatility
Lightman, S. L., Wiles, C. C., Atkinson, H. C., Henley, D. E., Russell, G. M., Leendertz, J. A., McKenna, M. A., Spiga, F., Wood, S. A., & Conway-Campbell, B. L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.073 · Cited by 241
“The importance of the rate limiting component of the cellular ubiquitin–proteasome system termed CHIP E3 ligase (carboxy terminus of heat shock protein 70-interacting protein E3 ligase) in glucocorticoid receptor regulation has been clearly shown in a series of experiments where cells naturally deficient in CHIP E3 li…”
BackgroundGlucocorticoid receptor physiology
Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F., & DeFranco, D. B. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9059-8 · Cited by 235
“In a cultured mouse hippocampal cell line, the inability of hormone treatment to trigger GR downregulation can be restored upon overexpression of the CHIP E3 ligase [ 91 ].”
BackgroundSelf-citationPost-translational modifications of steroid receptors
Faus, H., & Haendler, B. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.082 · Cited by 209
Adachi, H., Waza, M., Tokui, K., Katsuno, M., Minamiyama, M., Tanaka, F., Doyu, M., & Sobue, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1242-07.2007 · Cited by 157
Mechanisms of Glucocorticoid Action During Development
Busada, J. T., & Cidlowski, J. A. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.12.004 · Cited by 168
Conway-Campbell, B. L., McKenna, M. A., Wiles, C. C., Atkinson, H. C., de Kloet, E. R., & Lightman, S. L. (2007) · Endocrinology · doi:10.1210/en.2007-0585 · Cited by 125
“We do know that cell-specific relative expression of components of the ubiquitin proteasome pathway, in particular carboxy terminus of heat shock protein 70-interacting protein (CHIP) E3 ligase (42) and murine double min 2 (mdm2) (43), confers specificity for regulation of GR levels in varying conditions in vitro, and…”
BackgroundMorishima, Y., Wang, A. M., Yu, Z., Pratt, W. B., Osawa, Y., & Lieberman, A. P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn296 · Cited by 125
“GR (6), and there is good evidence that CHIP is the major E3 ligase involved in GR down-regulation after chronic exposure of HT22 cells to glucocorticoid (48).”
Liu, C., Lou, W., Yang, J. C., Liu, L., Armstrong, C. M., Lombard, A. P., Zhao, R., Noel, O. D. V., Tepper, C. G., Chen, H.-W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07178-x · Cited by 117
Kumamaru, E., Numakawa, T., Adachi, N., Yagasaki, Y., Izumi, A., Niyaz, M., Kudo, M., & Kunugi, H. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0264 · Cited by 116
Kinetic Complexity of the Global Response to Glucocorticoid Receptor Action
John, S., Johnson, T. A., Sung, M.-H., Biddie, S. C., Trump, S., Koch-Paiz, C. A., Davis, S. R., Walker, R., Meltzer, P. S., & Hager, G. L. (2009) · Endocrinology · doi:10.1210/en.2008-0863 · Cited by 102
CHIP: A Co-chaperone for Degradation by the Proteasome
Edkins, A. L. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-11731-7_11 · Cited by 107
The E3 Ligase CHIP: Insights into Its Structure and Regulation
Paul, I., & Ghosh, M. K. (2014) · BioMed Research International · doi:10.1155/2014/918183 · Cited by 96
“Evolutionary, CHIP is a well-conserved protein with an amino acid sequence similarity of ∼98% with mouse and ∼60% with the fruit fly [11].”
BackgroundLee, H., Sengupta, N., Villagra, A., Rezai-Zadeh, N., & Seto, E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01971-05 · Cited by 86
“CHIP has been implicated in the ubiquitination of many other proteins, including unfolded CFTR (38), glucocorticoid receptor ( 60 ), and E2A (24).”
BackgroundSionov, R. V., Spokoini, R., Kfir‐Erenfeld, S., Cohen, O., & Yefenof, E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00406-5 · Cited by 86
“Overexpression of CHIP restored hormone‐dependent downregulation of GR in these cells (Wang and DeFranco, 2005).”
BackgroundInfluentialJang, K. W., Lee, K. H., Kim, S. H., Jin, T., Choi, E. Y., Jeon, H. J., Kim, E., Han, Y. S., & Chung, J. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23292 · Cited by 82
Joshi, V., Amanullah, A., Upadhyay, A., Mishra, R., Kumar, A., & Mishra, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00093 · Cited by 78
Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer
Chen, C., Seth, A. K., & Aplin, A. E. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0182 · Cited by 81
“In addition to ErbB2, CHIP also promotes estrogen receptor a and glucocorticoid receptor degradation and attenuates receptor-mediated gene transcription (29, 150).”
BackgroundThe role of glucocorticoid receptors in metabolic syndrome and psychiatric illness
Moraitis, A. G., Block, T. S., Nguyen, D., & Belanoff, J. K. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.023 · Cited by 74
Witchel, S. F., & DeFranco, D. B. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0323 · Cited by 58
“Carboxy terminus of heat-shock protein 70 (hsp70)-interacting protein (also known as E3 ubiquitin protein ligase CHIP) has also been identified as an E3 ligase for the glucocorticoid receptor that promotes both hormone-independent and hormone-dependent degradation of the receptor”
Self-citationDaSilva, J. O., Gioeli, D. G., Weber, M. J., & Parsons, S. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4687 · Cited by 58
Tateishi, Y., Sonoo, R., Sekiya, Y.-I., Sunahara, N., Kawano, M., Wayama, M., Hirota, R., Kawabe, Y.-I., Murayama, A., Kato, S., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00713-06 · Cited by 68
Faresse, N., Ruffieux-Daidié, D., Salamin, M., Gómez-Sánchez, C. E., & Staub, O. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00285.2010 · Cited by 62
“In several cases, the ubiquitin-protein ligase CHIP has been reported to be the pivotal enzyme involved in the degradation of Hsp90 client protein, including some nuclear receptors such as GR, estrogen receptor- , aryl hydrocarbon receptor, or androgen receptor (8, 11, 24, 34, 56).”
BackgroundChaperone-assisted E3 ligase CHIP: A double agent in cancer
Kumar, S., Basu, M., & Ghosh, M. K. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.003 · Cited by 60
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
Noureddine, L. M., Trédan, O., Hussein, N., Badran, B. M., Romancer, M. L., & Poulard, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094446 · Cited by 59
“The E3 ligase CHIP (carboxy terminus of heat shock protein 70-interacting protein) was reported to be involved in this process where it modulates expression levels and activity of GR [83].”
BackgroundLysine 419 targets human glucocorticoid receptor for proteasomal degradation
Wallace, A. D., Cao, Y., Chandramouleeswaran, S., & Cidlowski, J. A. (2010) · Steroids · doi:10.1016/j.steroids.2010.06.015 · Cited by 54
“In the HT22 mouse hippocampal cell line, the mouse glucocorticoid receptor was shown to not undergo ligand dependent down-regulation, and CHIP overexpression was shown to restore GR down-regulation [36,43].”
BackgroundDisease- and treatment-associated acquired glucocorticoid resistance
Wilkinson, L., Verhoog, N. J. D., & Louw, A. (2018) · Endocrine Connections · doi:10.1530/ec-18-0421 · Cited by 57
Yemelyanov, A. Y., Bhalla, P., Yang, X. J., Ugolkov, A. V., Iwadate, K., Karseladze, A. I., & Budunova, I. V. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18945 · Cited by 57
A CHIPotle in physiology and disease
Paul, I., & Ghosh, M. K. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.027 · Cited by 47
GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
Louw, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01693 · Cited by 45
Ubiquitylation of nuclear receptors: new linkages and therapeutic implications
Helzer, K. T., Hooper, C., Miyamoto, S., & Alarid, E. T. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0308 · Cited by 45
“Other NRs also appear to be ubiquitylated by CHIP, including ERb, AR, GR and MR, suggesting that ubiquitylation of NRs by CHIP is a conserved mechanism (Cardozo et al. 2003, Wang & DeFranco 2005, Tateishi et al. 2006, Faresse et al. 2010).”
Zheng, Y., Cheng, X., Zhou, W., & Zhang, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.009 · Cited by 36
Stankowski, J. N., Zeiger, S. L. H., Cohen, E. L., DeFranco, D. B., Cai, J., & McLaughlin, B. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3300 · Cited by 35
“These cells are easy to transfect, reproducibly undergo glutamate-induced toxicity, and have many of the signaling systems essential for mediating ischemic injury (30, 46, 49).”
BackgroundMethodSelf-citationLesovaya, E. A., Yemelyanov, A. Y., Игоревич, К. К., Попа, А. В., Belitsky, G. A., Геннадиевна, Я. М., Gordon, L. I., Rosen, S. T., & Budunova, I. V. (2012) · Cell Cycle · doi:10.4161/cc.23048 · Cited by 35
“This hypothesis is based on the previous findings that 26S proteasome inhibitors stabilize GR in the presence and in the absence of glucocorticoids.(26,37,46,47) Definitely, BZ treatment increased GR protein levels in T- and B-lymphoid cells; however, the significant part of accumulated GR after BZ treatment remained…”
MethodKino, T., Liou, S.-H., Charmandari, E., & Chrousos, G. P. (2004) · Molecular Medicine · doi:10.2119/2005-00026.kino · Cited by 34
“mutant receptors hGRαR477H, V571A, D641V, G679S, V729I, I747M, L773P, (∆77-262), and GR(1-514) was examined by linear regression analysis and showed a significant positive correlation (Figure 5).”
BackgroundMethodInfluentialLu, L., Wang, D.-T., Shi, Y., Yin, Y., Wei, L.-B., Zou, Y.-C., Huang, B., Zhao, Y., Wang, M., Wan, H., et al. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.06.027 · Cited by 33
Spies, L.-M. L., Verhoog, N. J. D., & Louw, A. (2021) · Cells · doi:10.3390/cells10102529 · Cited by 36
CHIP: A new modulator of human malignant disorders
Cao, Z., Li, G., Shao, Q., Yang, G., Zheng, L., Zhang, T., & Zhao, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8219 · Cited by 34
“Interestingly, Hsp90 stabilizes associated client proteins, whereas Hsp70 promotes protein degradation by polyubiquitination [18].”
BackgroundUbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation
Garside, H., Waters, C. E., Berry, A., Rice, L., Ardley, H. C., White, A. E., Robinson, P. A., & Ray, D. W. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06799 · Cited by 33
“Indeed, overexpression of the mutant UbcH7 was sufficient to augment GR transactivation to levels achieved using the proteasome inhibitor MG132, but there was no further induction when MG132 and the UbcH7 mutant were used together.”
BackgroundInfluentialRen, Y., Xu, X., Mao, C.-Y., Han, K., Xu, Y., Cao, B., Zhang, Z.-B., Sethi, G., Tang, X., & Mao, X. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0309-6 · Cited by 29
Small-Molecule Hormones: Molecular Mechanisms of Action
Puzianowska‐Kuźnicka, M., Pawlik-Pachucka, E., Owczarz, M., Budzińska, M., & Połosak, J. (2013) · International Journal of Endocrinology · doi:10.1155/2013/601246 · Cited by 30
Regulation of Glucocorticoid Receptor Activity by a Stress Responsive Transcriptional Cofactor
Davies, L., Paraskevopoulou, E., Sadeq, M., Symeou, C., Pantelidou, C., Demonacos, C., & Krstic–Demonacos, M. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0212 · Cited by 30
Pandya, C. D., Kutiyanawalla, A., Turecki, G., & Pillai, A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.020 · Cited by 29
“Our data on GR transactivation is in agreement with a previous report that inhibition of proteasomal pathway results in the reduction of GR transactivation in neurons (Wang and DeFranco, 2005).”
ResultXenobiotics and the Glucocorticoid Receptor
Gulliver, L. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.02.003 · Cited by 28
CHIP: A Co-chaperone for Degradation by the Proteasome and Lysosome
Chakraborty, A., & Edkins, A. L. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-14740-1_12 · Cited by 26
Retinoids and glucocorticoids target common genes in hippocampal HT 22 cells
Brossaud, J., Roumes, H., Moisan, M., Pallet, V., Redonnet, A., & Corcuff, J. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12192 · Cited by 22
Novel role for receptor dimerization in post-translational processing and turnover of the GRα
Wilkinson, L., Verhoog, N. J. D., & Louw, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32440-z · Cited by 18
β-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling
Petrillo, M. G., Oakley, R. H., & Cidlowski, J. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007150 · Cited by 17
PFO5DoDA disrupts hepatic homeostasis primarily through glucocorticoid signaling inhibition
Wang, C., Fu, H., Yang, J., Liu, L., Zhang, F., Yang, C., Li, H., Chen, J., Li, Q., Wang, X., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.130831 · Cited by 17
Self-citationPatt, M., Gysi, J., Faresse, N., Cidlowski, J. A., & Odermatt, A. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110873 · Cited by 16
“…subjected to degradation by the ubiquitin-proteasome pathway, resulting in termination of the transcriptional response (Connell et al., 2001; Galigniana et al., 2004; Kinyamu and Archer, 2003; Sengupta and Wasylyk, 2001; Wallace and Cidlowski, 2001; Wang and DeFranco, 2005; Webster et al., 1997).”
BackgroundHu, Y., Jiang, Y., Zhang, Z., Wang, J., Zhang, B., Gong, L., Li, J., Pu, Z., Yang, X., Zou, J., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-1068 · Cited by 16
“Unique from other steroid receptors whose transcriptional activity are reduced upon ubiquitination processes, the transcriptional activity of GRa is enhanced upon entering the ubiquitin-proteasome degradation pathway (31).”
BackgroundModulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications
Liberman, A. C., Antunica-Noguerol, M., & ARZT, E. S. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101086 · Cited by 17
Pokhrel, S., Devi, S., & Gestwicki, J. E. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.11.004 · Cited by 12
Kim, B., Sasaki, A., Murphy, K. E., & Matthews, S. G. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01902-4 · Cited by 16
“The interaction between glucocorticoid exposure and the ubiquitin-proteasome system (UPS) has been thoroughly described [70, 71], highlighting an increased expression of ubiquitin following glucocorticoid exposure [72–74].”
BackgroundOrlovsky, M. (2012) · Biopolymers and Cell · doi:10.7124/bc.000061 · Cited by 7
Wu, C.-J., Livák, F., & Ashwell, J. D. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107581 · Cited by 4
“KMT2D is an enormous protein (5537 amino acids with a predicted molecular mass of about 600 kDa), and its interaction with the GR may physically prevent access of the ubiquitination machinery ( e.g. the E2 UbcH7 and the E3 CHIP, E6-AP and mdm2).”
Regulation of glucocorticoid receptor nuclear localization in prostate cancer cells
Chen, G., Lv, S., Pascal, L. E., & Wang, Z. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103577 · Cited by 4
Wang, J., Zhao, J., Li, J., Wang, F., & Su, Y. (2008) · Shock · doi:10.1097/shk.0b013e3181777c72 · Cited by 3
“Others have indicated that the GR could be targeted for destruction by the ubiquitin-proteasome pathway, which might be ignited by glucocorticoids (23, 24).”
BackgroundOakley, R. H., & Cidlowski, J. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_4 · Cited by 4
Yemelyanov, A. Y., Bhalla, P., Ugolkov, A. V., Yang, X. J., & Budunova, I. V. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3929 · Cited by 3
Jiménez‐Panizo, A., Johnson, T. A., Wagh, K., Alegre‐Martí, A., Montoya-Novoa, I., Lafuente, A. L., Eckhard, U., Rodríguez‐Lumbreras, L. A., Hoang, L., Stortz, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.13.653693 · Cited by 3
Potapova, S., Isakov, Y., Tyulkova, E. I., & Vetrovoy, O. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062873 · Cited by 2
Antunica-Noguerol, M., Aprile-Garcia, F., Budziñski, M. L., Proto-Cassina, L., Liberman, A. C., & ARZT, E. S. (2014) · Advances in Neuroimmune Biology · doi:10.3233/nib-140083 · Cited by 2
“Proteasome dependence is recovered when over-expressing the C-terminus of Hsc70-interacting protein (CHIP), an E3 ubiquitin ligase, which in turn alters GR transactivation activity [104, 105].”
BackgroundWang, S., Ekoue, D. N., Raj, G. V., & Kittler, R. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.010 · Cited by 2
CHIC2 and STUB1 regulate interferon-γ receptor cell surface expression
Rebeyev, N. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.45868 · Cited by 2
Wehmeyer, L. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 1
The role of p90 ribosomal S6 kinases (RSKs) in Steroid signalling
Cronin, R. (2019) · Open Access at Essex (University of Essex) · Cited by 2
The role of glucocorticoid receptors and mitogen-regulated protein kinases in the cochlea
Meltser, I. (2009) · Figshare
Role of C-terminus of HSC70 interacting protein in determining neuronal fate in acute injury
Stankowski, J. N. (2011)
Wadosky, K. M. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/b4hy-4b98
Al-Ibadi, I. N. A. (2017) · University of Salford Institutional Repository (University of Salford)
Genome-wide regulation of glucocorticoid signaling by SUMO modifications
Paakinaho, V. (2014) · UEF eRepo (University of Eastern Finland)
Glucocorticoid receptor activity in triple negative breast cancer
Noureddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/13ab50cfz7edbz4a44z918aza657b9614a4d · Cited by 1
Jiménez‐Panizo, A., Johnson, T. A., Wagh, K., Alegre‐Martí, A., Montoya-Novoa, I., Lafuente, A. L., Eckhard, U., Rodríguez‐Lumbreras, L. A., Hoang, L., Stortz, M., et al. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.15659398
Metadata
- Authors
- Wang, X., & DeFranco, D. B.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- DeFranco, Donald B.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-06-01
- Volume
- 19
- Issue
- 6
- Pages
- 1474-1482
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2121480898
- Cited by
- 77
- References
- 47
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 8 · 2013: 5 · 2012: 4
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA043037, CA 43037)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- glucocorticoid receptor, CHIP, E3 ubiquitin ligase, ubiquitin-proteasome system, receptor down-regulation, receptor transactivation, proteasome inhibition, HT22 cells, hippocampal neurons, chronic glucocorticoid exposure
- MeSH terms
- Animals, Cell Line, Genetic Vectors, Glucocorticoids, Hippocampus, Humans, Luciferases, Multienzyme Complexes, Neurons, Plasmids, Protease Inhibitors, Receptors, Glucocorticoid, Time Factors, Blotting, Western, Transcriptional Activation, Down-Regulation, Protein Structure, Tertiary, Genes, Reporter, Ubiquitin, Ubiquitin-Protein Ligases, Proteasome Endopeptidase Complex, Immunoprecipitation, Mice, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.